The purpose of this study was to create a new system for predicting the risk of glomerular and tubular dysfunctions (GTD) in patients with disorders of carbohydrate metabolism (DCM) based on standard parameters and new molecular markers for the development of kidney damage in patients with impaired glucose tolerance (IGT) and T2DM patients with diabetic nephropathy (DN).Material and Methods: The study included 69 patients: 16 patients with IGT (Group 1), 28 T2DM patients with microalbuminuria (Group 2), and 25 T2DM patients with macroalbuminuria (Group 3), according to the inclusion/exclusion criteria in the research. All patients were stratified by the MDRD. The control group (Group 4) included 11 healthy individuals. The duration of DN was 10.5 years. At the stage of data collection and screening, the standard methods of identification of IGT, DM and DN were applied. Additional methods are included quantitative analysis of the level of α-GST and π-GST, MMP-9 in urine by ELISA.Result: Based on the data of standard methods of identification of early and late acquired GTD in patients with DCM and new methods for assessment of metabolic profile of urine, we propose new prognostic markers of renal glomerular and tubular lesions in patients with IGT and T2DM. (International Journal of Biomedicine. 2017;7(3):208-212.)